Pub Date : 2026-01-30DOI: 10.1016/j.jns.2026.125769
Vincenzo Di Stefano, Nicasio Rini, Claudia Vinciguerra, Rita Frangiamore
{"title":"Considerations on comorbidity, chronic intravenous immunoglobulins, and methodological clarifications on ZILU25 study.","authors":"Vincenzo Di Stefano, Nicasio Rini, Claudia Vinciguerra, Rita Frangiamore","doi":"10.1016/j.jns.2026.125769","DOIUrl":"https://doi.org/10.1016/j.jns.2026.125769","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"482 ","pages":"125769"},"PeriodicalIF":3.2,"publicationDate":"2026-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146113544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-29DOI: 10.1016/j.jns.2026.125782
José Fidel Baizabal-Carvallo, Joseph Jankovic
Opisthotonus is characterized by backward arching of the trunk, associated with retrocollis, caused by involuntary contractions of extensor paraspinal muscles. Classical etiologies include tetanus, strychnine intoxication, dystonia (particularly tardive dystonia and neurodegeneration with brain iron accumulation), seizures, and functional movement disorders (MDs). Inborn errors of metabolism, epileptic encephalopathies and other gene mutations should be considered in newborns and infants presenting with opisthotonus. We surveyed 1216 consecutive patients presenting for evaluation in a tertiary care center for MDs and identified 17 (1.4%) with opisthotonus. Functional opisthotonus represented the most common cause, present in 9 (53%) patients. Other etiologies included tardive dystonia (n = 2), dystonia secondary to cavernous hemangioma in the basal ganglia (n = 1), dystonia due to hypoxic encephalopathy (n = 1), and 4 with idiopathic dystonia. Identifying the underlying etiology of opisthotonus is important to guide therapeutic strategies. Benzodiazepines, baclofen, anticholinergics, and botulinum toxin are common pharmacological options, whereas deep brain stimulation and surgical correction of the underlying cause should be considered in selected cases.
{"title":"Opisthotonus: Revisiting a classic movement disorder.","authors":"José Fidel Baizabal-Carvallo, Joseph Jankovic","doi":"10.1016/j.jns.2026.125782","DOIUrl":"https://doi.org/10.1016/j.jns.2026.125782","url":null,"abstract":"<p><p>Opisthotonus is characterized by backward arching of the trunk, associated with retrocollis, caused by involuntary contractions of extensor paraspinal muscles. Classical etiologies include tetanus, strychnine intoxication, dystonia (particularly tardive dystonia and neurodegeneration with brain iron accumulation), seizures, and functional movement disorders (MDs). Inborn errors of metabolism, epileptic encephalopathies and other gene mutations should be considered in newborns and infants presenting with opisthotonus. We surveyed 1216 consecutive patients presenting for evaluation in a tertiary care center for MDs and identified 17 (1.4%) with opisthotonus. Functional opisthotonus represented the most common cause, present in 9 (53%) patients. Other etiologies included tardive dystonia (n = 2), dystonia secondary to cavernous hemangioma in the basal ganglia (n = 1), dystonia due to hypoxic encephalopathy (n = 1), and 4 with idiopathic dystonia. Identifying the underlying etiology of opisthotonus is important to guide therapeutic strategies. Benzodiazepines, baclofen, anticholinergics, and botulinum toxin are common pharmacological options, whereas deep brain stimulation and surgical correction of the underlying cause should be considered in selected cases.</p>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"482 ","pages":"125782"},"PeriodicalIF":3.2,"publicationDate":"2026-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146105862","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-26DOI: 10.1016/j.jns.2026.125771
Megan M. Herr , Nisha M. Nair , Theresa Hahn , Chelsea Peterson , Jens Hillengass , Hillary Jacobson , Grant Schofield , Philip L. McCarthy , Ehsan Malek , Renee McKenzie , Hamza Hassan , Joseph D. Tario Jr , Maureen Ross , Marco L. Davila , Brian C. Betts , Shernan Holtan
{"title":"Pretreatment physical function as a risk factor for movement and neurocognitive treatment-emergent events (MNTs) in multiple myeloma (MM) patients treated with cilta-cel","authors":"Megan M. Herr , Nisha M. Nair , Theresa Hahn , Chelsea Peterson , Jens Hillengass , Hillary Jacobson , Grant Schofield , Philip L. McCarthy , Ehsan Malek , Renee McKenzie , Hamza Hassan , Joseph D. Tario Jr , Maureen Ross , Marco L. Davila , Brian C. Betts , Shernan Holtan","doi":"10.1016/j.jns.2026.125771","DOIUrl":"10.1016/j.jns.2026.125771","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"482 ","pages":"Article 125771"},"PeriodicalIF":3.2,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146090430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-26DOI: 10.1016/j.jns.2026.125772
Hannah-Lea Handelsmann , Lisa Herzog , Arnolt-Jan Hoving , Charles Majoie , Wim Van Zwam , Aad Van der Lugt , Susanne Wegener , for the MR CLEAN Investigators
Background
Mechanical thrombectomy (MT) is an effective treatment of large vessel occlusion (LVO) stroke. However, about 50% of patients do not achieve a favourable functional outcome after successful recanalisation by MT, considered as futile recanalisation (FR). We aimed at identifying factors associated with treatment response, vessel recanalisation and clinical outcome in LVO stroke patients randomised to MT and to predict FR to evaluate the effect of single predictors on patient outcome.
Methods
We performed a retrospective analysis of the MR CLEAN trial cohort. Ordinal logistic regression with interaction terms between a treatment indicator and patient factors was used to evaluate response to MT in terms of 3-months modified Rankin scale (mRS). In logistic regression, we identified factors associated with vessel recanalisation and FR. We predicted FR in a five-fold cross validation using least absolute shrinkage and selection operator (LASSO) regression.
Results
195 of the 461 included patients were randomised to receive MT. Male sex (OR 0.41, 95% CI 0.21–0.82, p = 0.01) enhanced the treatment effect of MT. Only onset-to-groin time was associated with a technically successful recanalisation (OR 0.99, 95% CI 0.99–1.00, p = 0.01). Higher age (OR 1.05, 95% CI 1.01–1.09, p = 0.02) and worse collateral score (OR 0.05, 95% CI 0.01–0.19, p < 0.01) were associated with FR. Female sex (OR 0.74) and worse collateral status (OR 0.19) showed the best predictive value for FR.
Conclusions
Different patient factors seem to be relevant for technical success and clinical success of MT in LVO stroke patients.
机械取栓术（MT）是治疗大血管闭塞（LVO）卒中的有效方法。然而，大约50%的患者在MT再通成功后没有达到良好的功能结果，被认为是无效的再通（FR）。我们的目的是确定随机分配到MT的LVO卒中患者的治疗反应、血管再通和临床结果的相关因素，并预测FR以评估单一预测因素对患者结果的影响。方法对MR CLEAN试验队列进行回顾性分析。采用具有治疗指标和患者因素之间相互作用项的有序逻辑回归，以3个月修正Rankin量表（mRS）评估MT的疗效。在逻辑回归中，我们确定了与血管再通和FR相关的因素。我们使用最小绝对收缩和选择算子（LASSO）回归进行了五倍交叉验证，预测了FR。结果461例纳入的患者中有195例被随机分配接受MT治疗。男性（OR 0.41, 95% CI 0.21-0.82, p = 0.01）增强了MT的治疗效果。只有从发作到腹股沟的时间与技术上成功的再通相关（OR 0.99, 95% CI 0.99 - 1.00, p = 0.01）。较高的年龄（OR 1.05, 95% CI 1.01-1.09, p = 0.02）和较差的侧支评分（OR 0.05, 95% CI 0.01 - 0.19, p < 0.01）与FR相关。女性（OR 0.74）和较差的侧支状态（OR 0.19）是FR的最佳预测价值。结论不同的患者因素似乎与左脑卒中患者MT的技术成功和临床成功相关。
{"title":"Futile recanalisation in patients with anterior large vessel occlusion stroke randomised to mechanical thrombectomy","authors":"Hannah-Lea Handelsmann , Lisa Herzog , Arnolt-Jan Hoving , Charles Majoie , Wim Van Zwam , Aad Van der Lugt , Susanne Wegener , for the MR CLEAN Investigators","doi":"10.1016/j.jns.2026.125772","DOIUrl":"10.1016/j.jns.2026.125772","url":null,"abstract":"<div><h3>Background</h3><div>Mechanical thrombectomy (MT) is an effective treatment of large vessel occlusion (LVO) stroke. However, about 50% of patients do not achieve a favourable functional outcome after successful recanalisation by MT, considered as futile recanalisation (FR). We aimed at identifying factors associated with treatment response, vessel recanalisation and clinical outcome in LVO stroke patients randomised to MT and to predict FR to evaluate the effect of single predictors on patient outcome.</div></div><div><h3>Methods</h3><div>We performed a retrospective analysis of the MR CLEAN trial cohort. Ordinal logistic regression with interaction terms between a treatment indicator and patient factors was used to evaluate response to MT in terms of 3-months modified Rankin scale (mRS). In logistic regression, we identified factors associated with vessel recanalisation and FR. We predicted FR in a five-fold cross validation using least absolute shrinkage and selection operator (LASSO) regression.</div></div><div><h3>Results</h3><div>195 of the 461 included patients were randomised to receive MT. Male sex (OR 0.41, 95% CI 0.21–0.82, <em>p</em> = 0.01) enhanced the treatment effect of MT. Only onset-to-groin time was associated with a technically successful recanalisation (OR 0.99, 95% CI 0.99–1.00, <em>p</em> = 0.01). Higher age (OR 1.05, 95% CI 1.01–1.09, <em>p</em> = 0.02) and worse collateral score (OR 0.05, 95% CI 0.01–0.19, <em>p</em> < 0.01) were associated with FR. Female sex (OR 0.74) and worse collateral status (OR 0.19) showed the best predictive value for FR.</div></div><div><h3>Conclusions</h3><div>Different patient factors seem to be relevant for technical success and clinical success of MT in LVO stroke patients.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"482 ","pages":"Article 125772"},"PeriodicalIF":3.2,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146090429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.1016/j.jns.2026.125768
Yao Yang , Ye Hu
{"title":"Letter to the editor: Early real-life experience on Zilucoplan for generalized myasthenia gravis: ZILU25 multicenter observational study","authors":"Yao Yang , Ye Hu","doi":"10.1016/j.jns.2026.125768","DOIUrl":"10.1016/j.jns.2026.125768","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"482 ","pages":"Article 125768"},"PeriodicalIF":3.2,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146048951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Authors' reply to comment letter on ZILU25 study","authors":"Vincenzo Di Stefano , Claudia Vinciguerra , Michelangelo Maestri Tassoni , Rita Frangiamore","doi":"10.1016/j.jns.2026.125758","DOIUrl":"10.1016/j.jns.2026.125758","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"481 ","pages":"Article 125758"},"PeriodicalIF":3.2,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146035239","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1016/j.jns.2026.125767
Francisco Jover-Diaz , Lucia Parra-Muñoz , Mar Trigueros-Rocamora , Elisabet Delgado-Sánchez , Pedro Esteve-Atiénzar , Jorge Peris-García
Objective
To systematically analyze published clinical cases of upper limb plexopathy secondary to herpes zoster (HZ) to clarify epidemiology, clinical features, diagnostic methods, treatments, and outcomes.
Background
Plexopathy caused by HZ is a rare neurological complication predominantly affecting older adults. Despite scattered case reports, knowledge gaps remain regarding its incidence, pathophysiology, management, and prognosis. This review addresses these gaps by synthesizing individual patient data with a rigorous methodology.
Methods
A systematic review adhering to PRISMA-IPD guidelines was conducted by searching PubMed, Scopus, and EMBASE from 2000 to 2025 for case reports and series of HZ-associated upper limb plexopathy published in English, Spanish, or French. Data extracted included demographics, clinical manifestations, electrophysiological and imaging findings, treatments, and outcomes.
Results
Sixty articles describing 123 patients (mean age 69.5 years, balanced sex distribution) met inclusion criteria. Most patients presented with mixed motor and sensory nerve involvement, primarily involving C5-C6 dermatomes. Common comorbidities included diabetes mellitus and immunosuppression. Treatment typically combined antivirals, neuropathic pain management, and rehabilitation. Complete recovery occurred in 47% of cases, partial improvement in most others, while 27% experienced persistent sequelae. Delayed diagnosis, immunosuppression, pure axonal EMG patterns, and age over 70 years were associated with worse outcomes.
Conclusions
This PRISMA-IPD systematic review provides the most comprehensive synthesis to date on HZ-associated brachial plexopathy, emphasizing the importance of early clinical and electrophysiological diagnosis and multimodal treatment. Findings underscore the need for standardized diagnostic protocols and prospective studies to improve patient management and prognosis in this rare but disabling condition.
{"title":"Upper limb plexopathy secondary to herpes zoster: A PRISMA-guided systematic case review","authors":"Francisco Jover-Diaz , Lucia Parra-Muñoz , Mar Trigueros-Rocamora , Elisabet Delgado-Sánchez , Pedro Esteve-Atiénzar , Jorge Peris-García","doi":"10.1016/j.jns.2026.125767","DOIUrl":"10.1016/j.jns.2026.125767","url":null,"abstract":"<div><h3>Objective</h3><div>To systematically analyze published clinical cases of upper limb plexopathy secondary to herpes zoster (HZ) to clarify epidemiology, clinical features, diagnostic methods, treatments, and outcomes.</div></div><div><h3>Background</h3><div>Plexopathy caused by HZ is a rare neurological complication predominantly affecting older adults. Despite scattered case reports, knowledge gaps remain regarding its incidence, pathophysiology, management, and prognosis. This review addresses these gaps by synthesizing individual patient data with a rigorous methodology.</div></div><div><h3>Methods</h3><div>A systematic review adhering to PRISMA-IPD guidelines was conducted by searching PubMed, Scopus, and EMBASE from 2000 to 2025 for case reports and series of HZ-associated upper limb plexopathy published in English, Spanish, or French. Data extracted included demographics, clinical manifestations, electrophysiological and imaging findings, treatments, and outcomes.</div></div><div><h3>Results</h3><div>Sixty articles describing 123 patients (mean age 69.5 years, balanced sex distribution) met inclusion criteria. Most patients presented with mixed motor and sensory nerve involvement, primarily involving C5-C6 dermatomes. Common comorbidities included diabetes mellitus and immunosuppression. Treatment typically combined antivirals, neuropathic pain management, and rehabilitation. Complete recovery occurred in 47% of cases, partial improvement in most others, while 27% experienced persistent sequelae. Delayed diagnosis, immunosuppression, pure axonal EMG patterns, and age over 70 years were associated with worse outcomes.</div></div><div><h3>Conclusions</h3><div>This PRISMA-IPD systematic review provides the most comprehensive synthesis to date on HZ-associated brachial plexopathy, emphasizing the importance of early clinical and electrophysiological diagnosis and multimodal treatment. Findings underscore the need for standardized diagnostic protocols and prospective studies to improve patient management and prognosis in this rare but disabling condition.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"481 ","pages":"Article 125767"},"PeriodicalIF":3.2,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146035161","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a subtype of acute encephalopathy diagnosed based on its characteristic clinical course and imaging findings. However, AESD presents with various symptoms and diverse neurological outcomes. We aimed to identify prognostic factors for AESD by analyzing clinical data.
Methods
This retrospective study included patients diagnosed with AESD at our institution between 1997 and 2015. 57 patients (29 male and 28 female) were included for analysis, with a median age at onset of 13 months (interquartile range: 11–22 months). Short-term outcome was defined as neurological status at 6 months post-onset, and long-term outcome as status at more than 2 years post-onset. Patients were categorized into favorable (Pediatric Cerebral Performance Category [PCPC] 1–2) and unfavorable (PCPC 3–6) outcome groups. We reviewed the clinical course, laboratory data (blood and cerebrospinal fluid during the early and late seizure phases), magnetic resonance imaging (MRI) findings, and treatment interventions. Univariate and multivariate logistic regression analyses were conducted to identify prognostic factors (p < 0.05 was considered statistically significant).
Results
In the multivariate analysis, extensive MRI lesions were significantly associated with poor short-term outcomes (p = 0.009, odds ratio [OR] 8.333), while edaravone use was significantly associated with favorable long-term outcomes (p = 0.007, OR 0.105).
Conclusions
The extent of MRI lesions predicted short-term outcomes, while edaravone administration was associated with improved long-term outcomes in patients with AESD.
{"title":"Analysis of prognostic factors in acute encephalopathy with biphasic seizures and late reduced diffusion: a retrospective study on MRI findings and the treatments","authors":"Masataka Fukuoka , Ichiro Kuki , Megumi Nukui , Takeshi Inoue , Hideo Okuno , Junichi Ishikawa , Yasunori Otsuka , Kiyoko Amo , Masao Togawa , Hiroshi Rinka , Masashi Shiomi , Shin Okazaki","doi":"10.1016/j.jns.2026.125760","DOIUrl":"10.1016/j.jns.2026.125760","url":null,"abstract":"<div><h3>Background</h3><div>Acute encephalopathy with biphasic seizures and late reduced diffusion (AESD) is a subtype of acute encephalopathy diagnosed based on its characteristic clinical course and imaging findings. However, AESD presents with various symptoms and diverse neurological outcomes. We aimed to identify prognostic factors for AESD by analyzing clinical data.</div></div><div><h3>Methods</h3><div>This retrospective study included patients diagnosed with AESD at our institution between 1997 and 2015. 57 patients (29 male and 28 female) were included for analysis, with a median age at onset of 13 months (interquartile range: 11–22 months). Short-term outcome was defined as neurological status at 6 months post-onset, and long-term outcome as status at more than 2 years post-onset. Patients were categorized into favorable (Pediatric Cerebral Performance Category [PCPC] 1–2) and unfavorable (PCPC 3–6) outcome groups. We reviewed the clinical course, laboratory data (blood and cerebrospinal fluid during the early and late seizure phases), magnetic resonance imaging (MRI) findings, and treatment interventions. Univariate and multivariate logistic regression analyses were conducted to identify prognostic factors (<em>p</em> < 0.05 was considered statistically significant).</div></div><div><h3>Results</h3><div>In the multivariate analysis, extensive MRI lesions were significantly associated with poor short-term outcomes (<em>p</em> = 0.009, odds ratio [OR] 8.333), while edaravone use was significantly associated with favorable long-term outcomes (<em>p</em> = 0.007, OR 0.105).</div></div><div><h3>Conclusions</h3><div>The extent of MRI lesions predicted short-term outcomes, while edaravone administration was associated with improved long-term outcomes in patients with AESD.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"482 ","pages":"Article 125760"},"PeriodicalIF":3.2,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146048952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1016/j.jns.2026.125763
Anel Karisik , Stefan Kiechl , Michael Knoflach , Lukas Mayer-Suess
{"title":"Author response: Impact of dysphagia on early psychosocial consequences after acute ischemic stroke","authors":"Anel Karisik , Stefan Kiechl , Michael Knoflach , Lukas Mayer-Suess","doi":"10.1016/j.jns.2026.125763","DOIUrl":"10.1016/j.jns.2026.125763","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"481 ","pages":"Article 125763"},"PeriodicalIF":3.2,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146018918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-19DOI: 10.1016/j.jns.2026.125764
Yang Gao, Yingjie Lu, Xiaofei Li
{"title":"Commentary on “Impact of dysphagia on early psychosocial consequences after acute ischemic stroke”","authors":"Yang Gao, Yingjie Lu, Xiaofei Li","doi":"10.1016/j.jns.2026.125764","DOIUrl":"10.1016/j.jns.2026.125764","url":null,"abstract":"","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"481 ","pages":"Article 125764"},"PeriodicalIF":3.2,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146030082","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号